Junin virus activity in two rural populations of the Argentine hemorrhagic fever (AHF) endemic area. 1983

M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui

To determine the prevalence of inapparent infection with Junin virus among the rural population and its relation to the clinical disease, a serological study was carried out in two zones of the endemic area of Argentine hemorrhagic fever (AHF). From the first appearance of AHF in the zones (1963) and the moment of the survey (1977), 14 years had passed. A total of 695 serum samples were obtained, 540 from Córdoba and 155 from Buenos Aires. Of the 695 serum samples, 83 were positive for neutralizing antibodies against Junin virus. Total infection (clinical and inapparent cases) reached 11.6% and 12.03% in the Buenos Aires and Córdoba zones, respectively, showing that the total prevalence of infection in two zones separated by 320 miles, are very much alike. In Córdoba province, the prevalence of clinical infection was 7.59%, while that for inapparent infection was 4.44%. Values for the Province of Buenos Aires were 9.67% and 1.93%, respectively. In addition to a low prevalence of inapparent infections, the results of this survey show that roughly 90% of the population is susceptible to contract the disease; this stresses the need to immunize susceptible individuals in the endemic area.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006477 Arenaviruses, New World One of two groups of viruses in the ARENAVIRUS genus and considered part of the New World complex. It includes JUNIN VIRUS; PICHINDE VIRUS; Amapari virus, and Machupo virus among others. They are the cause of human hemorrhagic fevers mostly in Central and South America. Amapari virus,Chapare mammarenavirus,Hemorrhagic Fever Virus, Bolivian,Hemorrhagic Fever Viruses, American,Machupo virus,New World Arenaviruses,Sabia virus,Tacaribe virus,Allpahuayo virus,American Hemorrhagic Fever Virus,Chapare virus,Guanarito virus,Pirital virus,Tacaribe Complex Viruses,Allpahuayo viruses,Chapare mammarenaviruses,Chapare viruses,Guanarito viruses,Pirital viruses,Tacaribe viruses,viruses, Tacaribe
D006478 Hemorrhagic Fever, American Diseases caused by American hemorrhagic fever viruses (ARENAVIRUSES, NEW WORLD). American Hemorrhagic Fever,Argentine Hemorrhagic Fever,Bolivian Hemorrhagic Fever,Brazilian Hemorrhagic Fever,Hemorrhagic Fever, Argentinian,Hemorrhagic Fever, Bolivian,Hemorrhagic Fever, Brazilian,Junin virus Infection,Machupo virus Infection,Sabia virus Infection,American Hemorrhagic Fevers,Argentinian Hemorrhagic Fever,Bolivian Hemorrhagic Fevers,Brazilian Hemorrhagic Fevers,Fever, American Hemorrhagic,Fever, Argentine Hemorrhagic,Fever, Argentinian Hemorrhagic,Fever, Bolivian Hemorrhagic,Fever, Brazilian Hemorrhagic,Hemorrhagic Fever, Argentine,Infection, Junin virus,Infection, Machupo virus,Infection, Sabia virus,Junin virus Infections,Machupo virus Infections,Sabia virus Infections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
May 1969, Comptes rendus des seances de la Societe de biologie et de ses filiales,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
November 1994, The American journal of tropical medicine and hygiene,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
January 1979, Intervirology,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
January 1966, Archiv fur die gesamte Virusforschung,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
January 2023, Medicina,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
January 1974, Medicina,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
January 1972, Medicina,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
December 1992, The American journal of tropical medicine and hygiene,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
May 2014, Journal of virology,
M C Weissenbacher, and M S Sabattini, and M M Avila, and P M Sangiorgio, and M R de Sensi, and M S Contigiani, and S C Levis, and J I Maiztegui
January 1986, Intervirology,
Copied contents to your clipboard!